An MRI-based study found that progression of white matter involvement in the brain among patients with infantile-onset Pompe disease…
Steve Bryson, PhD
Steve holds a PhD in biochemistry from the Faculty of Medicine at the University of Toronto, Canada. As a medical scientist for 18 years, he worked in both academia and industry, where his research focused on the discovery of new vaccines and medicines to treat inflammatory disorders and infectious diseases. Steve is a published author in multiple peer-reviewed scientific journals and a patented inventor.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Steve Bryson, PhD
A newborn boy was diagnosed with both infantile-onset Pompe disease (IOPD) and sickle cell disease (SCD) in the…
Stem cell-mediated gene therapy normalized glycogen build-up in muscle, heart, and brain tissue of a Pompe disease mouse model,…
In an interview study, mothers of children who tested positive for Pompe disease in genetic newborn screening programs —…
Most children with Pompe disease in a small study developed antibodies against the enzyme replacement therapy Myozyme (alglucosidase alfa)…
Adults with late-onset Pompe disease in the U.K reported a long and distressing diagnostic process, with most patients calling…
Based on a literature and database analysis, the predicted genetic prevalence of disease-related variants in the GAA gene — the…
A large-scale analysis of the proteins and lipids found in the blood of people with…
Whole-body MRI found that a muscle in the shin is affected early on in children…
People with late-onset Pompe disease (LOPD) show significant increases in the amount of muscle replaced by fat…